New Buy tip from Market Investor - 95p target price, pt 129 Oct 2020 10:12
Https://masterinvestor.co.uk/equities/sdi-group-could-covid-19-have-been-good-for-this-digital-imaging-group/?mc_cid=c3861b8617&mc_eid=db9f9bbaf2
""SDI Group – could Covid-19 have been ‘good’ for this digital imaging group?
By Mark Watson-Mitchell 28 October 2020
Already bouncing back from the pandemic, SDI Group has bags of potential to expand, writes Mark Watson-Mitchell.
On Wednesday 9 December this designer and manufacturer of scientific and technology products will announce its interim results for the six months ending this coming Saturday. They should report some encouraging management confidence, certainly good enough to give impetus to its share price.
Previously known as Scientific Digital Imaging, the SDI Group (LON:SDI) designs and manufactures scientific and technology products for use in digital imaging and sensing control applications by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets.
The group has some 11 brands through which it operates.
SDI has a strategy of continuing to grow by developing its own technology advancements and by improving its global sales channels, while also adding to its strength by pursuing strategic, complementary acquisitions.
On Thursday of last week chairman Ken Ford, a ‘markets man’ of no mean ability, informed shareholders that the group had made a very good start to the current financial year.
Apparently two of the group’s brands, Atik Cameras (which is the group’s largest business) and MPB Industries, secured significant contracts to supply cameras and flowmeters, respectively, for PCR DNA amplifiers and for respirators. Both are benefiting from one-time contracts in this year.
(Polymerase chain reaction, or PCR, is a laboratory technique used to make multiple copies of a segment of DNA. PCR is very precise and can be used to amplify, or copy, a specific DNA target from a mixture of DNA molecules.)
Understandably the need for digital imaging and sensing and control products, particularly in the life science and medical industries, has been robust and there has been strong demand for several of the group’s products for use in the fight against the Covid-19 pandemic.
Understandably the need for digital imaging and sensing and control products, particularly in the life science and medical industries, has been robust and there has been strong demand for several of the group’s products for use in the fight against the Covid-19 pandemic.
The group has worked hard to keep its businesses profitable and cash generative in the first half, all have remained operational during the pandemic, with customer orders beginning to show a return to the pre-Covid-19 levels.
In fact, the group’s management believes that it will achieve revenues and profitability similar to its expectations for the year prior to the ‘lockdown’. In just over a month’s time we will see just how well the group has actually performed."